Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum.
about
Nutlin-3a, an MDM2 antagonist and p53 activator, helps to preserve the replicative potential of cancer cells treated with a genotoxic dose of resveratrolBiochemical effects of SIRT1 activatorsUnderstanding the molecular mechanisms of cancer prevention by dietary phytochemicals: From experimental models to clinical trialsDrug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An OverviewNew concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkersProperties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and HumansResearch progress on chemopreventive effects of phytochemicals on colorectal cancer and their mechanismsMetabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficaciesResveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell linesNatural product-based inhibitors of hypoxia-inducible factor-1 (HIF-1).Resveratrol suppresses IGF-1 induced human colon cancer cell proliferation and elevates apoptosis via suppression of IGF-1R/Wnt and activation of p53 signaling pathways.Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders.Inhibition of mammary tumor growth and metastases to bone and liver by dietary grape polyphenols.Neuronutrition and Alzheimer's diseaseRepeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisResults of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancerResveratrol: challenges in translation to the clinic--a critical discussion.Antioxidant and anti-inflammatory effects in RAW264.7 macrophages of malvidin, a major red wine polyphenol.Grape polyphenols inhibit Akt/mammalian target of rapamycin signaling and potentiate the effects of gefitinib in breast cancer.Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.The sustained delivery of resveratrol or a defined grape powder inhibits new blood vessel formation in a mouse model of choroidal neovascularization.Resveratrol--pills to replace a healthy diet?Inhibitory effects of resveratrol and pterostilbene on human colon cancer cells: a side-by-side comparisonSubchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity.Determination of resveratrol and its sulfate and glucuronide metabolites in plasma by LC-MS/MS and their pharmacokinetics in dogs.Effects of a grape-supplemented diet on proliferation and Wnt signaling in the colonic mucosa are greatest for those over age 50 and with high arginine consumptionOncogenicity evaluation of resveratrol in p53(+/-) (p53 knockout) mice.Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet.Analysis of resveratrol as a lung cancer chemopreventive agent in A/J mice exposed to benzo[a]pyreneCancer chemoprevention: Evidence of a nonlinear dose response for the protective effects of resveratrol in humans and miceCombined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model.Low concentrations of resveratrol inhibit Wnt signal throughput in colon-derived cells: implications for colon cancer preventionResveratrol: Biological and pharmaceutical properties as anticancer molecule.Pilot study of resveratrol in older adults with impaired glucose tolerance.trans-Resveratrol, an extract of red wine, inhibits human eosinophil activation and degranulationA Derivative Method with Free Radical Oxidation to Predict Resveratrol Metabolites by Tandem Mass SpectrometryCharacterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activityResveratrol-induced gene expression profiles in human prostate cancer cells.Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways.Pre-formulation studies of resveratrol.
P2860
Q24595171-0AA16D98-79FA-4F1C-97C0-6E7F9DCDF72DQ24633830-F5B39335-8EF8-4EDA-8F05-AB1331F1741BQ26765196-54B0294A-2FD1-4CCD-B695-D7130436D187Q26767516-9DE29A95-B2E4-4D75-850E-42ECE573E9E9Q26774577-7FC729E6-5953-4595-B4E4-9AD42B7E81FBQ26801926-671CB581-E8FC-464B-B030-D806FC61EFC0Q28067369-CCEA8383-897D-4892-AA2E-B5F24E504BCBQ28477935-85925507-B654-47D8-81E7-1956483DA1C5Q28539044-66EB22A4-089C-476A-AD70-9870C72AC7BEQ33235403-1BC5DC3D-3A70-48C8-BC08-C8E6F78588ACQ33588231-99E62EFA-2A55-4C7B-AD1B-FEFD5438039BQ33827813-10762CC3-5DD8-44EF-9F0A-A8F431E46910Q33967930-B264D028-AF17-4D7A-ABB0-53D6E263DAEDQ34099466-5EBC3E9C-B4F2-490C-A402-4E3FC65D597AQ34316229-F448D2FF-E3B7-42C2-9DB7-2435B6AB9FE1Q34418424-A8797BA9-688D-4993-BE8E-AA25E5689307Q34673721-4734B5E0-86F9-4C18-8793-428BF002CEF1Q34766423-FF0B792C-FA10-492A-990F-D9A42091D565Q34855692-CD7EBAE4-EDA3-41E0-9F13-EA8AB793209EQ34880559-9B54E09E-8343-4990-9857-6F338AF4D6F6Q35036502-AF93151D-4679-4ED1-8A0B-4AB06DBB178FQ35120581-374DBF32-F121-40E1-8BFA-DEC8180009DEQ35445753-285F3501-02CA-4CE6-9F12-4A89DE9DCC53Q35570811-40092596-7790-4A49-92FB-90E4B31E7DB4Q35607205-E6FE5BBA-7453-46E9-86CE-61F8D7E8DB03Q35755288-B1BAC9DD-21A6-4D25-9BB8-CE7E9749DDA7Q35758133-98A30711-916B-4D67-BB94-C52FE1FE6463Q36586516-EEDBD6F8-66F2-4918-B392-D47C485E8BFFQ36695705-8D0AABA9-2A23-4D99-BBB8-22B8C0324E58Q36786996-2DFCB1D1-8F7D-421A-ACA4-6D5F10CE3111Q36831357-0FFBACB0-5778-4F34-B897-B99A02584635Q36844294-1235D304-F2DA-4A36-906B-AB78B24DAAE1Q36848141-275A0055-BCC4-4FC3-B774-363D1662059EQ36895103-C836F628-D426-4963-AD57-E39124BCE775Q37002367-C367FFFB-8725-4017-9511-435A427D9524Q37213230-0B7F7278-FF48-4DCC-88AB-50676224C612Q37355419-7EF22E97-C66F-417F-B6CA-90684EE89CC9Q37467489-C12E47FF-B93D-4F1D-8899-273ACF8B76B9Q39156783-EDAFBC6B-C03D-4D15-B915-B6636F04A9BBQ40541694-7852276B-C0F3-4443-BAA3-078D0FD7477B
P2860
Relationship between mechanisms, bioavailibility, and preclinical chemopreventive efficacy of resveratrol: a conundrum.
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Relationship between mechanism ...... y of resveratrol: a conundrum.
@ast
Relationship between mechanism ...... y of resveratrol: a conundrum.
@en
Relationship between mechanism ...... y of resveratrol: a conundrum.
@nl
type
label
Relationship between mechanism ...... y of resveratrol: a conundrum.
@ast
Relationship between mechanism ...... y of resveratrol: a conundrum.
@en
Relationship between mechanism ...... y of resveratrol: a conundrum.
@nl
prefLabel
Relationship between mechanism ...... y of resveratrol: a conundrum.
@ast
Relationship between mechanism ...... y of resveratrol: a conundrum.
@en
Relationship between mechanism ...... y of resveratrol: a conundrum.
@nl
P1476
Relationship between mechanism ...... cy of resveratrol: a conundrum
@en
P2093
Andreas J Gescher
William P Steward
P304
P577
2003-10-01T00:00:00Z